ROSE IDEMILI: Open Payments
NPI 1912779885 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $85 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
| ABBVIE INC. | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: REXULTI, AUSTEDO XR, CAPLYTA, COBENFY, VRAYLAR, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
